carbamates has been researched along with AIDS Seroconversion in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amprenavir was administered on either a twice-daily (b." | 2.70 | Pharmacokinetic and pharmacodynamic study of the human immunodeficiency virus protease inhibitor amprenavir after multiple oral dosing. ( Gillotin, C; Lou, Y; Sadler, BM; Stein, DS, 2001) |
| "In an open-label, randomized, multicenter, multiple-dose pharmacokinetic study, we determined the steady-state pharmacokinetics of amprenavir with and without coadministration of indinavir, nelfinavir, or saquinavir soft gel formulation in 31 human immunodeficiency virus type 1-infected subjects." | 2.70 | Pharmacokinetic study of human immunodeficiency virus protease inhibitors used in combination with amprenavir. ( Eron, JJ; Gillotin, C; Haubrich, R; Lang, W; Lou, Y; Sadler, BM; Stein, DS, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Aluzaite, K | 1 |
| Fraser, M | 1 |
| Johnson, S | 1 |
| Giles, H | 1 |
| Schultz, M | 1 |
| Steiner, S | 1 |
| Bucsics, T | 1 |
| Schwabl, P | 1 |
| Mandorfer, M | 1 |
| Scheiner, B | 1 |
| Aichelburg, MC | 1 |
| Grabmeier-Pfistershammer, K | 1 |
| Ferenci, P | 1 |
| Trauner, M | 1 |
| Peck-Radosavljevic, M | 1 |
| Reiberger, T | 1 |
| Lattuada, E | 1 |
| Lanzafame, M | 1 |
| Grosso, C | 1 |
| Soldani, F | 1 |
| Corsini, F | 1 |
| Storato, S | 1 |
| Vento, S | 1 |
| Guffanti, M | 1 |
| De Pascalis, CR | 1 |
| Seminari, E | 1 |
| Fusetti, G | 1 |
| Gianotti, N | 1 |
| Bassetti, D | 1 |
| Galli, A | 1 |
| Castagna, A | 1 |
| Lazzarin, A | 1 |
| Mauss, S | 1 |
| Scholten, S | 1 |
| Wolf, E | 1 |
| Berger, F | 1 |
| Schmutz, G | 1 |
| Jaeger, H | 1 |
| Kurowski, M | 1 |
| Rockstroh, JK | 1 |
| Sadler, BM | 2 |
| Gillotin, C | 2 |
| Lou, Y | 2 |
| Stein, DS | 2 |
| Eron, JJ | 1 |
| Lang, W | 1 |
| Haubrich, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection[NCT00002183] | Phase 1 | 60 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for carbamates and AIDS Seroconversion
| Article | Year |
|---|---|
A prospective, controlled study assessing the effect of lopinavir on amprenavir concentrations boosted by ritonavir.
Topics: Anti-HIV Agents; Carbamates; Drug Interactions; Drug Therapy, Combination; Furans; HIV Protease Inhi | 2004 |
Pharmacokinetic and pharmacodynamic study of the human immunodeficiency virus protease inhibitor amprenavir after multiple oral dosing.
Topics: Adolescent; Adult; Anti-HIV Agents; Area Under Curve; Carbamates; Dideoxynucleosides; Female; Furans | 2001 |
Pharmacokinetic study of human immunodeficiency virus protease inhibitors used in combination with amprenavir.
Topics: Adult; Area Under Curve; Carbamates; CD4 Lymphocyte Count; Cytochrome P-450 CYP3A; Cytochrome P-450 | 2001 |
4 other studies available for carbamates and AIDS Seroconversion
| Article | Year |
|---|---|
Successful use of generic direct acting antiviral medications to treat hepatitis C-a New Zealand-wide study.
Topics: Aged; Antiviral Agents; Benzimidazoles; Carbamates; Drug Therapy, Combination; Drugs, Generic; Femal | 2020 |
Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna.
Topics: 2-Naphthylamine; Adult; AIDS-Related Opportunistic Infections; Anilides; Anti-HIV Agents; Antiviral | 2017 |
Optimal fosamprenavir regimen to prevent lipid abnormalities.
Topics: Adult; Anti-HIV Agents; Carbamates; Drug Therapy, Combination; Female; Furans; HIV Protease Inhibito | 2009 |
Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients.
Topics: Adult; Atazanavir Sulfate; Carbamates; Drug Administration Schedule; Drug Therapy, Combination; Fema | 2003 |